HCG METHODS FOR CHRONIC PAIN MANAGEMENT AND TREATMENT USING HCG

摘要

Gonadotropin is administered within a narrow range that is very effective for the purpose of treating chronic pain or other central sensitized sequelae. In one aspect, HCG is provided in a human subcutaneous dose of 120 IU / day to 170 IU / day, more preferably, 140 IU / day to 160 IU / day, or an equivalent human subcutaneous dose selected As such, at least one of human chorionic gonadotropin (uHCG and / or rHCG), a pharmaceutically active HCG analog, and a pharmaceutically active metabolite of HCG or analog is provided to the recipient. The kit is also described as including a supply, delivery device, and label for identifying chronic pain or central sensitization as an indication for a drug associated with HCG.